HEADER TRANSCRIPTION 05-OCT-22 8B94 TITLE CRYSTAL STRUCTURE OF PPARG AND NCOR2 WITH BAY-5516, AN INVERSE AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NUCLEAR RECEPTOR COREPRESSOR 2; COMPND 8 CHAIN: C, D; COMPND 9 SYNONYM: N-COR2,CTG REPEAT PROTEIN 26,SMAP270,SILENCING MEDIATOR OF COMPND 10 RETINOIC ACID AND THYROID HORMONE RECEPTOR,SMRT,T3 RECEPTOR- COMPND 11 ASSOCIATING FACTOR,TRAC,THYROID-,RETINOIC-ACID-RECEPTOR-ASSOCIATED COMPND 12 COREPRESSOR; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR HORMONE RECEPTOR TRANSCRIPTION FACTOR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR A.FRIBERG,D.L.ORSI,E.POOK,S.SIEGEL,C.T.LEMKE,T.STELLFELD,V.PUETTER, AUTHOR 2 J.GOLDSTEIN REVDAT 3 01-MAY-24 8B94 1 REMARK REVDAT 2 04-JAN-23 8B94 1 JRNL REVDAT 1 28-DEC-22 8B94 0 JRNL AUTH D.L.ORSI,S.J.FERRARA,S.SIEGEL,A.FRIBERG,L.BOUCHE,E.POOK, JRNL AUTH 2 P.LIENAU,J.P.BLUCK,C.T.LEMKE,G.AKCAY,T.STELLFELD,H.MEYER, JRNL AUTH 3 V.PUTTER,S.J.HOLTON,D.KORR,I.JERCHEL-FURAU,C.PANTELIDOU, JRNL AUTH 4 C.A.STRATHDEE,M.MEYERSON,K.EIS,J.T.GOLDSTEIN JRNL TITL DISCOVERY AND CHARACTERIZATION OF ORALLY BIOAVAILABLE JRNL TITL 2 4-CHLORO-6-FLUOROISOPHTHALAMIDES AS COVALENT PPARG JRNL TITL 3 INVERSE-AGONISTS. JRNL REF BIOORG.MED.CHEM. V. 78 17130 2022 JRNL REFN ESSN 1464-3391 JRNL PMID 36542958 JRNL DOI 10.1016/J.BMC.2022.117130 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 85468 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4499 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6387 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.61 REMARK 3 BIN R VALUE (WORKING SET) : 0.3400 REMARK 3 BIN FREE R VALUE SET COUNT : 336 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4163 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 357 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.13000 REMARK 3 B22 (A**2) : 0.34000 REMARK 3 B33 (A**2) : -0.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.089 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.089 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.082 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.426 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4372 ; 0.011 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4348 ; 0.002 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5895 ; 1.686 ; 1.658 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10035 ; 1.555 ; 1.593 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 531 ; 5.034 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 204 ;31.069 ;23.873 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 841 ;14.769 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;13.930 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 573 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4835 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 943 ; 0.009 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 8B94 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1292125669. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, EMBL C/O DESY REMARK 200 BEAMLINE : P14 (MX2) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 89998 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 60.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INTERNAL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350 20%, HCOOK 0.2 M, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.22200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.63550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.94800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.63550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.22200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.94800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 199 REMARK 465 SER A 200 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 ASP A 462 REMARK 465 MET A 463 REMARK 465 SER A 464 REMARK 465 LEU A 465 REMARK 465 GLU A 471 REMARK 465 ILE A 472 REMARK 465 TYR A 473 REMARK 465 LYS A 474 REMARK 465 ASP A 475 REMARK 465 LEU A 476 REMARK 465 TYR A 477 REMARK 465 GLY B 199 REMARK 465 SER B 200 REMARK 465 HIS B 201 REMARK 465 MET B 202 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ASP B 243 REMARK 465 LYS B 244 REMARK 465 LYS B 261 REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 THR B 461 REMARK 465 ASP B 462 REMARK 465 MET B 463 REMARK 465 SER B 464 REMARK 465 LEU B 465 REMARK 465 HIS B 466 REMARK 465 PRO B 467 REMARK 465 LEU B 468 REMARK 465 LEU B 469 REMARK 465 GLN B 470 REMARK 465 GLU B 471 REMARK 465 ILE B 472 REMARK 465 TYR B 473 REMARK 465 LYS B 474 REMARK 465 ASP B 475 REMARK 465 LEU B 476 REMARK 465 TYR B 477 REMARK 465 HIS C 2343 REMARK 465 ALA C 2344 REMARK 465 SER C 2345 REMARK 465 THR C 2346 REMARK 465 ASN C 2347 REMARK 465 MET C 2348 REMARK 465 GLY C 2360 REMARK 465 LYS C 2361 REMARK 465 TYR C 2362 REMARK 465 ASP C 2363 REMARK 465 GLN C 2364 REMARK 465 TRP C 2365 REMARK 465 HIS D 2343 REMARK 465 ALA D 2344 REMARK 465 SER D 2345 REMARK 465 THR D 2346 REMARK 465 ASN D 2347 REMARK 465 MET D 2348 REMARK 465 LYS D 2361 REMARK 465 TYR D 2362 REMARK 465 ASP D 2363 REMARK 465 GLN D 2364 REMARK 465 TRP D 2365 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 267 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 411 O HOH A 601 2.02 REMARK 500 O HOH A 741 O HOH A 791 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 234 NE - CZ - NH1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ARG A 234 NE - CZ - NH2 ANGL. DEV. = -5.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 259 31.40 -87.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 810 DISTANCE = 5.84 ANGSTROMS DBREF 8B94 A 203 477 UNP P37231 PPARG_HUMAN 231 505 DBREF 8B94 B 203 477 UNP P37231 PPARG_HUMAN 231 505 DBREF 8B94 C 2343 2365 UNP Q9Y618 NCOR2_HUMAN 2332 2354 DBREF 8B94 D 2343 2365 UNP Q9Y618 NCOR2_HUMAN 2332 2354 SEQADV 8B94 GLY A 199 UNP P37231 EXPRESSION TAG SEQADV 8B94 SER A 200 UNP P37231 EXPRESSION TAG SEQADV 8B94 HIS A 201 UNP P37231 EXPRESSION TAG SEQADV 8B94 MET A 202 UNP P37231 EXPRESSION TAG SEQADV 8B94 GLY B 199 UNP P37231 EXPRESSION TAG SEQADV 8B94 SER B 200 UNP P37231 EXPRESSION TAG SEQADV 8B94 HIS B 201 UNP P37231 EXPRESSION TAG SEQADV 8B94 MET B 202 UNP P37231 EXPRESSION TAG SEQRES 1 A 279 GLY SER HIS MET GLN LEU ASN PRO GLU SER ALA ASP LEU SEQRES 2 A 279 ARG ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SEQRES 3 A 279 SER PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU SEQRES 4 A 279 THR GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR SEQRES 5 A 279 ASP MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS SEQRES 6 A 279 PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU SEQRES 7 A 279 VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER SEQRES 8 A 279 VAL GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER SEQRES 9 A 279 ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL SEQRES 10 A 279 THR LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR SEQRES 11 A 279 MET LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SEQRES 12 A 279 SER GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SEQRES 13 A 279 SER LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS SEQRES 14 A 279 PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP SEQRES 15 A 279 ASP SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SEQRES 16 A 279 SER GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE SEQRES 17 A 279 GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU SEQRES 18 A 279 GLN LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE SEQRES 19 A 279 ALA LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE SEQRES 20 A 279 VAL THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS SEQRES 21 A 279 THR GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU SEQRES 22 A 279 ILE TYR LYS ASP LEU TYR SEQRES 1 B 279 GLY SER HIS MET GLN LEU ASN PRO GLU SER ALA ASP LEU SEQRES 2 B 279 ARG ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SEQRES 3 B 279 SER PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU SEQRES 4 B 279 THR GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR SEQRES 5 B 279 ASP MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS SEQRES 6 B 279 PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU SEQRES 7 B 279 VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER SEQRES 8 B 279 VAL GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER SEQRES 9 B 279 ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL SEQRES 10 B 279 THR LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR SEQRES 11 B 279 MET LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SEQRES 12 B 279 SER GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SEQRES 13 B 279 SER LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS SEQRES 14 B 279 PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP SEQRES 15 B 279 ASP SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SEQRES 16 B 279 SER GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE SEQRES 17 B 279 GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU SEQRES 18 B 279 GLN LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE SEQRES 19 B 279 ALA LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE SEQRES 20 B 279 VAL THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS SEQRES 21 B 279 THR GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU SEQRES 22 B 279 ILE TYR LYS ASP LEU TYR SEQRES 1 C 23 HIS ALA SER THR ASN MET GLY LEU GLU ALA ILE ILE ARG SEQRES 2 C 23 LYS ALA LEU MET GLY LYS TYR ASP GLN TRP SEQRES 1 D 23 HIS ALA SER THR ASN MET GLY LEU GLU ALA ILE ILE ARG SEQRES 2 D 23 LYS ALA LEU MET GLY LYS TYR ASP GLN TRP HET Q5O A 501 32 HET Q5O B 501 32 HETNAM Q5O ~{N}3-[4-[BIS(FLUORANYL)METHOXY]-2-METHYL-PHENYL]-4- HETNAM 2 Q5O CHLORANYL-6-FLUORANYL-~{N}1-[(4-FLUOROPHENYL) HETNAM 3 Q5O METHYL]BENZENE-1,3-DICARBOXAMIDE FORMUL 5 Q5O 2(C23 H17 CL F4 N2 O3) FORMUL 7 HOH *357(H2 O) HELIX 1 AA1 ASN A 205 PHE A 226 1 22 HELIX 2 AA2 THR A 229 THR A 238 1 10 HELIX 3 AA3 ASP A 251 ILE A 262 1 12 HELIX 4 AA4 GLU A 276 SER A 302 1 27 HELIX 5 AA5 GLY A 305 LEU A 309 5 5 HELIX 6 AA6 ASP A 310 LEU A 333 1 24 HELIX 7 AA7 ARG A 350 LEU A 356 1 7 HELIX 8 AA8 PRO A 359 PHE A 363 5 5 HELIX 9 AA9 MET A 364 ALA A 376 1 13 HELIX 10 AB1 ASP A 380 LEU A 393 1 14 HELIX 11 AB2 ASN A 402 HIS A 425 1 24 HELIX 12 AB3 GLN A 430 GLU A 460 1 31 HELIX 13 AB4 ASN B 205 PHE B 226 1 22 HELIX 14 AB5 THR B 229 THR B 238 1 10 HELIX 15 AB6 ASP B 251 GLU B 259 1 9 HELIX 16 AB7 GLU B 276 SER B 302 1 27 HELIX 17 AB8 GLY B 305 LEU B 309 5 5 HELIX 18 AB9 ASP B 310 ALA B 331 1 22 HELIX 19 AC1 SER B 342 GLY B 344 5 3 HELIX 20 AC2 ARG B 350 SER B 355 1 6 HELIX 21 AC3 PRO B 359 PHE B 363 5 5 HELIX 22 AC4 MET B 364 ALA B 376 1 13 HELIX 23 AC5 ASP B 380 LEU B 393 1 14 HELIX 24 AC6 ASN B 402 HIS B 425 1 24 HELIX 25 AC7 GLN B 430 GLU B 460 1 31 HELIX 26 AC8 LEU C 2350 MET C 2359 1 10 HELIX 27 AC9 LEU D 2350 GLY D 2360 1 11 SHEET 1 AA1 4 PHE A 247 ILE A 249 0 SHEET 2 AA1 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA1 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 AA1 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 AA2 4 PHE B 247 ILE B 249 0 SHEET 2 AA2 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 AA2 4 GLY B 338 ILE B 341 -1 N VAL B 339 O MET B 348 SHEET 4 AA2 4 MET B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 LINK SG CYS A 285 C4 Q5O A 501 1555 1555 1.70 LINK SG CYS B 285 C4 Q5O B 501 1555 1555 1.70 CISPEP 1 LYS A 358 PRO A 359 0 1.69 CISPEP 2 LYS B 358 PRO B 359 0 1.38 CRYST1 60.444 85.896 121.271 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016544 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011642 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008246 0.00000